Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.

US FDA approves Regeneron’s gene therapy, Otarmeni for genetic hearing loss: Tarrytown, New York Regeneron Pharmaceuticals, Inc., a leadi ...

By H.E. Dr. Jean Kaseya, Director General, Africa CDCAs Africa marks World Malaria Day 2026, one fact remains inescapable: malaria continues to impose one of the heaviest and most avoidable burdens on ...

Alan Rappeport and Ephrat Livni* With oil prices in mind, the administration of US President Donald Trump has deployed a ...

With oil prices in mind, the Trump administration has deployed a haphazard approach to sanctions on Russia and Iran.

As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...

By the time April arrived this year, emergency rooms across most of the country were already seeing tick-bite patients at ...

•Why disease still loses significant threatMalaria continues to pose a significant public health threat in Nigeria, remaining a perilous disease that affects millions annually. In this report, VINCENT ...

The news of Singapore’s foreign minister building an AI assistant for himself using NanoClaw to answer diplomacy questions has been doing the ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best stem cell therapy stocks to buy. TD Cowen lifted the price ...

An ‌overnight Russian drone attack on Ukraine's southern city of Odesa wounded 10 people, including two children, and damaged residential buildings, Ukrainian officials said on Monday. The strikes ...